Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
07 Novembre 2023 - 2:00PM
Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage
oncology company developing MasterKey therapies that target
families of oncogenic mutations in patients with genetically
defined cancers, today announced that its President and Chief
Executive Officer, Mark A. Velleca, M.D., Ph.D., will participate
in fireside chats during two upcoming investor conferences:
- The Stifel 2023 Healthcare Conference at 2:25pm ET on Tuesday,
November 14, 2023, in New York, NY.
- The Piper Sandler 35th Annual
Healthcare Conference at 4:30pm ET on Wednesday, November 29, 2023,
in New York, NY.
Webcasts will be available at the start of the
presentations on the investor relations section of the Company’s
website, www.blackdiamondtherapeutics.com. Replays of the
presentations will also be available and archived on the site for
90 days.
About Black Diamond
TherapeuticsBlack Diamond Therapeutics is a clinical-stage
oncology company focused on the development of MasterKey therapies
that address families of oncogenic mutations in clinically
validated targets. The Company’s MasterKey therapies are designed
to address broad genetically defined patient populations, overcome
resistance, minimize wild-type mediated toxicities, and be
brain-penetrant to treat CNS disease. The Company is advancing two
clinical-stage programs: BDTX-1535, a brain-penetrant fourth
generation EGFR MasterKey inhibitor targeting EGFR mutant NSCLC and
GBM, and BDTX-4933, a brain-penetrant RAF MasterKey inhibitor
targeting KRAS, NRAS and BRAF alterations in solid tumors. For more
information, please visit www.blackdiamondtherapeutics.com.
Contacts
For Investors:Mario Corso, Head of Investor
Relations, Black Diamond Therapeuticsmcorso@bdtx.com
Julie Seidel, Stern Investor
Relationsinvestors@bdtx.com
For Media:media@bdtx.com
Black Diamond Therapeutics (NASDAQ:BDTX)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Black Diamond Therapeutics (NASDAQ:BDTX)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024